id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0022-0026,FDA,FDA-1978-N-0022,Letter from the Consumer Healthcare Products Association (CHPA) to FDA/DDM,Other,Letter(s),2012-03-06T05:00:00Z,2012,3,2012-03-06T05:00:00Z,,2020-04-13T15:30:43Z,,0,0,0900006480fcffbf
FDA-1978-N-0022-0027,FDA,FDA-1978-N-0022,Attachment A - Adverse Events Reported to Manufacturers of OTC External Analgesic Patch Products July 2009 through April 2011 re: Letter from the Consumer Healthcare Products Association (CHPA) to FDA/DDM,Supporting & Related Material,Background Material,2012-03-06T05:00:00Z,2012,3,,,2020-04-13T15:33:05Z,,0,0,0900006480fcffc1
FDA-1978-N-0022-0024,FDA,FDA-1978-N-0022,External Analgesic Drug Products for OTC Human Use; Reopening of the Administrative Record and Amendment of Tentative Final Monograph Published 7/17/2003,Notice,NPR-Notice of Proposed Rule-Making,2010-03-17T04:00:00Z,2010,3,2010-03-17T04:00:00Z,,2010-04-29T18:06:14Z,,0,0,0900006480abf290
FDA-1978-N-0022-0021,FDA,FDA-1978-N-0022,"Answer from FDA/CDER to Letter from AAC Consulting Group, Inc. to FDA/CDER",Other,Answer,2006-05-25T04:00:00Z,2006,5,,,2020-02-04T13:36:35Z,,0,0,090000648055eca0
FDA-1978-N-0022-0023,FDA,FDA-1978-N-0022,Letter from FDA/CDER to Bayer Corporation,Other,Letter(s),2006-05-25T04:00:00Z,2006,5,,,2020-02-04T13:39:10Z,,0,0,090000648055eca2
FDA-1978-N-0022-0022,FDA,FDA-1978-N-0022,Letter from FDA/CDER to Otis Clapp,Other,Letter(s),2006-05-25T04:00:00Z,2006,5,,,2020-02-04T13:38:23Z,,0,0,090000648055eca1
FDA-1978-N-0022-0020,FDA,FDA-1978-N-0022,External Analgesic Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record and Amendment of Tentative Final Monograph,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-07-17T04:00:00Z,2003,7,2003-07-15T04:00:00Z,2003-10-16T03:59:59Z,2020-02-05T16:13:10Z,03-17934,0,0,090000648055ec5f
FDA-1978-N-0022-0019,FDA,FDA-1978-N-0022,Antifungal Drug Products for Over-the-Counter Human Use; External Analgesic Drug Products for Over-the-Counter Human Use; Skin Protectant Drug Products for Over-the-Counter Human Use; and Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Reopening of Administrative Records,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1997-11-21T05:00:00Z,1997,11,1997-11-21T05:00:00Z,1998-02-18T04:59:59Z,2020-02-04T12:52:44Z,97-30410,0,0,090000648055ebe7